abcam
Contact Us

Overview


Join Dr George Prendergast as he discusses the future of Immunochemotherapy, focusing on the convergence of cross-disciplinary themes

Cancer biologists, pharmacologists and immunologists have historically communicated little with each other due to different traditions in training and a lack of integrated perspectives on cancer. Immunologists have been oriented mainly to biological therapies and they have tended to have less knowledge of genetics and pharmacology.



Topics

  • An introduction to Cancer Immunotherapy
  • Development of cross-disciplinary themes within the field
  • Key advances in how to degrade the immunosuppressive barriers raised by tumors
  • Review of Sessions (4th International Conference on Immunochemotherapy)


  • Watch now




    Abcam will process your personal data in strict accordance with its privacy policy which can be found here. This will include sending you updates about Abcam, our products, and resources we think would be of interest to you. You can unsubscribe and manage your marketing preferences by clicking the link at the bottom of every email we send. By filling out this form you consent to Abcam sharing your details with your local, authorized distributor for the purpose of answering your query.

    Meet our presenter

    Webinar image

    Meet our presenter

    Dr George Prendergast

    Dr Prendergast received his PhD in Molecular Biology from Princeton University. Following postdoctoral work at HHMI and Merck Research Laboratories, he was appointed to the faculty of The Wistar Institute as a Pew Scholar in the Biomedical Sciences.

    abcam

    Join with us

    • Linkedin
    • Facebook
    • Twitter
    • Google Plus
    • Terms
    • Privacy policy
    • Legal

    © 1998-2017 Abcam plc. All rights reserved.